The purpose of this study was to determine the quantity and nature of the mucins synthesized and secreted by four different pancreatic cancer cell lines. Well-to moderately-differentiated SW1990 and CAPAN-2 human pancreatic cancer cells were found to produce more high-Mr glycoprotein (HMG) than less-differentiated MIA PaCa-2 and PANC-1 cells. Most of the labelled HMG was secreted within 24 h. The results of chemical and enzymic degradation, ion-exchange chromatography and density-gradient centrifugation indicated that the HMG in SW1990 and CAPAN-2 cells has the properties expected for mucins, whereas much of the HMG in MIA PaCa-2 and PANC-1 cells may not be mucin, but proteoglycan. These results are consistent with immunoblots and Northern blots showing the presence of apomucin and apomucin mRNA in SW1990 and CAPAN-2 cells, but not in MIA PaCa-2 and PANC-1 cells. The Western blots and Northern blots also show that SW1990 and CAPAN-2 cells, like breast cancer cells, have the mammary-type apomucin and mRNA coded by the MUCI gene, but lack the intestinal type apomucin and mRNA coded by the MUC2 gene. In contrast, the colon cancer cell lines tested in culture express apomucin and mRNA coded by MUC2 but not by MUCI.
INTRODUCTION
Mucins are high-M, glycoproteins (HMGs) with a high content of O-glycosidically-linked carbohydrate which are produced by several types of epithelial tissues. Many pancreatic-cancerassociated antigens have been found to be present on mucins. These include CA19-9 [1] , DU-PAN-2 [2] , YPan-I and SPan-I [3] , all of which are carbohydrate-specific antigens. Little is known about the relative amounts of mucin made by different pancreatic cancer cells or about the types of protein backbone (apomucin) present in pancreatic mucins. The purpose of this study was to determine the quantitative and qualitative differences in the mucins synthesized and secreted by different pancreatic cancer cell lines which show different degrees of differentiation. We investigated four such cell lines, SW 1990 [41 and CAPAN-2 [5] , which are well-to moderately well-differentiated, and MIA PaCa-2 [6] and PANC-1 [7] , which are poorly differentiated. In addition to their different degrees of differentiation, SW1990 [4] and CAPAN-2 [51 cells were chosen because they have been previously shown to produce SPan-1 and YPan-1 cancer-associated mucin antigens [3] . MIA PaCa-2 [6] and PANC-1 cells [7] have been reported to produce high-Mr sulphate-containing glycoconjugates, which have not been well characterized [8, 9] .
We also sought to determine what type of mucin polypeptide was present in pancreatic cancer cells. Two human mucins have recently been characterized; the mammary mucin encoded by the MUCI (also designated PUM or PEM) gene [10, 11] , and the intestinal mucin encoded by the MUC2 (or SMUC) gene [12] . Although these two mucins are distinct, both polypeptides have extended regions of tandemly repeated amino acids. The MUCJgene-encoded protein contains 20-amino-acid tandem repeats that contain five threonine and serine residues per repeat unit, which can serve as sites for O-glycosylation. The SMUC-or MUC2-gene-encoded protein, on the other hand, has a 23-amino-acid repeat, and is much richer in potential O-glycosylation sites with 14 threonine residues. The mucin polypeptides (apomucins) can be studied with antibodies against breast cancer apomucin such as 139H2 [13, 14] , DF3 [15] and HMFG2 [16] , antibodies against colon cancer apomucin such as anti-MRP [12] or anti-HFB [17] , as well as an antibody against pancreatic cancer apomucin, anti-SWB [18] . Likewise, the cDNA clones for MUC1 and MUC2 can be used to examine expression at the level of mRNA by Northern blot analysis.
MATERIALS AND METHODS

Cell lines and cell culture
Human pancreatic adenocarcinoma cell lines SW1990 [4J, CAPAN-2 [5] , MIA PaCa-2 [6] and PANC-1 [7] were grown in Dulbecco's modified Eagle's medium (DME) containing 10% fetal calf serum (FCS) 100 units of penicillin/ml and 100 4ug of streptomycin sulphate/ml. Cultures were maintained at 37°C in a humidified 7 % CO2 atmosphere. [19, 20] . After a 24 h labelling period, flasks were chilled on ice, the cell layer was removed using a rubber scraper and the flasks were rinsed with phosphate- Vol. 276 buffered saline (PBS). After centrifugation (10 min in a Beckman T-J-6 centrifuge at 170 g), the supernatant was designated as 'medium fraction' and the cell pellet was sonicated on ice in 10 mM-Tris buffer, pH 8.0. The cell homogenate was subjected to ultracentrifugation (O00000 g, 1 h) and the supernatant was designated as 'cytosol fraction'.
Gel filtration of labelled glycoproteins
The medium and cytosol fractions were subjected to gel filtration on Sepharose CL-4B (Pharmacia, Uppsala, Sweden) columns with dimensions of 1.27 cm x 30 cm. Samples of 1 ml were applied to the columns and were eluted with 10 mmTris/HCl buffer, pH 8.0. Fractions of 1.2 ml were collected from the column and counted for radioactivity in a scintillation counter.
Chemical and enzymic degradation
[3H]Glucosamine-labelled HMGs, which were purified from medium fractions of cells labelled with 10 luCi of PH]-glucosamine/ml, were pooled, dialysed against distilled water and lyophilized. They were analysed after the following treatments. Reductive cleavage ofO-glycosidic linkages by fl-elimination was done in 50 mM-NaOH/IM-NaBH4at 50°C for 48 h.
Trypsin (25 ug/ml) digestion was done at 37°C for 24 h in 50 mM-Tris/HCI, pH 8.0 [21] . Bovine [25] .
The column was eluted with a discontinuous NaCl gradient (0-300 mM-NaCl in 50 mm increments) in 10 mM-Tris, pH 8.0, followed by 1 % acetic acid. Fractions of 3 ml were collected and 1 ml of each fraction was counted for radioactivity.
CsCI gradient ultracentrifugation
To the [3H]glucosamine-labelled void volume fractions collected from media of the four cell lines, CsCl (0.54 g/ml) was added, and the CsCI solution was centrifuged for 72 h at 1.6 x I05 g in a Beckman SW-41 rotor at 5°C. Fractions of 1.0 ml were removed, weighed to determine density and counted for 3H.
Glycosyltransferase activity
The glycosyltransferase assays used in this study were modifications ofearlier methods [26] .The assays using triplicate samples were repeated three times in each cell line. The assay mixtures for polypeptidyl N-acetylgalactosaminyltransferase and /11,3-galactosyltransferase contained 0.1M-cacodylate buffer, pH 6.8,
The reaction mixtures were incubated at 37°C for 90 min and were then precipitated with 1 % phosphotungstic acid in 0.5M-HCI. Net radioactivity transferred to the exogenously added acceptors was determined after subtracting the endogenous activity.
SDS/PAGE and Western blots
Electrophoresis was performed according to the method of Laemmli [27] , with a 7 % polyacrylamide running gel and a 4% stacking gel. Samples (homogenates of the four pancreatic cancer cell lines, and of two colon cancer cell lines, HM7 [28] and H498 [29] , as well as two breast cancer cell lines, MCF7 [30] and ZR-75-1 [31] ) were heated at 100°C in 2.5% mercaptoethanol and labelled probe/ml and 10% dextran sulphate were used. The membranes were then washed with 2 x SSC containing 0.1 % SDS for 1.5 h at room temperature, followed by 1 h washes at room temperature and then I h at 55°C in 0.1 x SSC/0.1 % SDS. After these washings, the membranes were autoradiographed. After autoradiography, blots were erased, checked for residual radioactivity and rehybridized with subsequent probes. The MUCI cDNA clone, PUM24P, was isolated from a Agtl 1 cDNA library prepared from the cell line MCF7, kindly provided by P. Chambon (University of Strasborg). The first screening was done using the monoclonal antibody LICR.LON M8 [38] , kindly provided by the Ludwig Institute for Cancer Research (London, U.K.). This antibody recognizes the MUCJ gene products on immunoblotting [39, 40] , and there was prior evidence that it recognized a protein epitope [38] . Antibody-positive recombinants were further screened using an oligonucleotide (30-mer) synthesized from the published repeat sequence [41, 42] (Table 3) . We conclude that SW1990 and CAPAN-2 cells secreted over 15-fold more mucin than MIA PaCa-2 and PANC-I cells.
DEAE-cellulose chromatography
The [3H]glucosamine-labelled HMGs purified by gel filtration of SW1990 and CAPAN-2 cell medium had peak III (eluted by 150 mM-NaCl) as their major component (Figs. Ia and lb) . The HMGs from the medium of MIA PaCa-2 and PANC-1 cells, however, had peak V (eluted by 250 mM-NaCl) as their major component (Figs. Ic and ld). When unlabelled SW1990 xenograft mucin [18] , detected by binding of peroxidase-labelled Ricinus communis agglutinin, was chromatographed in the same fashion, peak III was also the major species (results not shown). These data indicate that the HMG of MIA PaCa-2 and PANC-I cells is more acidic than that of SW1990 and CAPAN-2 cells, consistent with the conclusion that the HMG in SW1990 and CAPAN-2 cells is mucin, while much of the HMG in MIA PaCa-2 PANC-1 cells is proteoglycan.
CsCI gradient ultracentrifugation
The HMGs purified from the medium by gel filtration on Sepharose CL-4B were further examined on density gradients. In SWI990 and CAPAN-2 cells, the peak of 3H was found at a density of 1.405 g/ml and 1.432 g/ml respectively (Figs. 2a and  2b) . However, in MIA PaCa-2 and PANG-I cells, the peak of 3H was found at a density around 1.50 g/ml (Figs. 2c and 2d ). This result is also consistent with the conclusion that the majority of the HMG of SW 1990 and CAPAN-2 cells is mucin, but that the majority of the HMG of MIA PaCa-2 and PANC-l cells is not mucin, but proteoglycan.
Glycosyltransferase activity CAPAN-2 and, to a lesser extent, SW1990 cells had higher levels of polypeptidyl N-acetylgalactosaminyltransferase and fl1,3-galactosyltransferase than did MIA PaCa-2 and PANC-1 cells (Table 4) . However, the difference in enzyme activity was not as great as the differences in the extent of [3H]glucosamine incorporation ( Table 1) .
Comparison of apomucin among pancreatic, colonic and breast cancer cell lines
The nature of mucin polypeptides was studied in the cell homogenates of pancreatic (SW1990, CAPAN-2, MIA PaCa-2, PANC-1), colonic (HM7, H498) and breast (MCF7, ZR-75-1) cancer cells by immunoblot analysis. When the immunoblots were incubated with monoclonal antibody against the breast cancer apomucin, 139H2 (Fig. 3a) When the immunoblots were incubated with antibody against a synthetic mucin repeat peptide of colon cancer apomucin, anti-MRP (Fig. 3b) , HM7 cells showed an intense band at the -top of the 7 acrylamide separating gel, though there were weak bands of apparent Mr 100000 and 165000, and a weak broad band of When immunoblots were incubated with antibody against pancreatic cancer apomucin, anti-SWB (Fig. 3c ), SW1990 and CAPAN-2 cells showed two discrete bands of apparent Mr 165000 and 230000 that coincided with those detected by 139H2. Northern blot analysis MUCI mRNA was detected in SW1990 and CAPAN-2 cells and in the breast cell lines as expected [10, 11] , although the message level in MCF7 was somewhat lower than the others (Fig. 4a) . The other two pancreatic cancer cell lines and the two colon cancer cell lines showed little or no apomucin mRNA detected by MUCI cDNA. Only the two colon cancer cell lines, HM7 and H498, showed apomucin mRNA detectable by MUC2 cDNA, which codes for colon cancer-type apomucin [12] (Fig. 4b) . Both Previous studies indicate that human pancreatic ductal epithelium synthesizes and secretes mucin [43] . Most pancreatic carcinomas are believed to arise from the ductal epithelium [44] . The SW1990 cell line was established from a Grade II adenocarcinoma, forms xenograft tumours similar to the original neoplasm in nude mice, and has characteristics of ductal epithelium [4] . Although the extent of differentiation of the original tumours from which the CAPAN-2 cell line was established is not known [5] , it forms a well-differentiated ductal cell adenocarcinoma in nude mouse xenograft (Y. S. Kim, unpublished work). The MIA PaCa-2 cell line was established from an undifferentiated carcinoma [6] and has less ductal-like characteristics [8] . This difference between these cell lines seems to be correlated with the difference in mucin production between them. The PANC-1 cell line, which was established from an undifferentiated carcinoma and forms anaplastic carcinoma in nude mice [7] , has maintained some of the differentiated characteristics of normal pancreatic ductal epithelial cells [9] . PANC-1 cells secrete more labelled HMG than do MIA PaCa-2 cells, but most of it seems to be not a mucin but a proteoglycan. Madden et al. [8, 9] found that MIA PaCa-2 and PANC-l cells synthesize
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From the results of immunoblots and Northern blots, we conclude that the two well-to moderately-differentiated pancreatic cancer cell lines, SW1990 and CAPAN-2, like the two breast cancer cell lines, express the MUCI gene but not the MUC2 gene. The differences between cell lines in the electrophoretic mobility of the immunoreactive MUCI proteins (Fig. 3) are consistent with the polymorphism, due to a variable number of tandem repeats, in the MUCI gene [10,1 1] .
Anti-SWB, which is an antibody against completely deglycosylated SW1990 xenograft mucin [18] , detected bands that are similar in electrophoretic mobilities to those stained by 139H2, DF3 and HMFG2 monoclonal antibodies. Thus anti-SWB seems to react with MUCI gene products. However, anti-SWB also reacted with colon cancer cells, which express the MUC2 gene but not the MUCI gene. Since anti-SWB, like anti-MRP, reacted with colon cancer cell products mainly at the top of the separating gel, anti-SWB seems also to react with MUC2 gene products. This suggests that SW1990 xenografts, unlike SW1990 cells in culture, express not only breast cancer cell type mucin (MUCJ gene product), but also colon cancer cell type mucin (MUC2 gene product). This difference in expression may reflect a situation similar to that observed previously for the LS174T colon cancer cell line, which expresses much more mucin in xenografts than in cell culture [45] .
Recently, Lan et al. [46, 47] reported that pancreatic apomucin and breast apomucin share some similarity in tandem-repeated nucleic acid and protein sequences. Cloning and sequencing of cDNAs from the HPAF pancreatic cancer cell line [471 confirmed the presence of MUCI mucin almost identical to that in breast cancer cell lines [48, 49] . Our results in pancreatic and breast cancer cell lines are consistent with their results. In addition, we also observed that both pancreatic and breast cancer cells lack colon-cancer-type apomucin. Thus there seems to be an obvious difference in the apomucin present in pancreatic and breast cancer cells in comparison with that in colon cancer cells.
Further studies will be necessary to resolve the questions of whether pancreatic cancer cells have other distinct types ofmucins, and how regulation of the type of mucin expressed differs in cultured cells and in xenografts.
